Modern Hasen Pharma Building $43.6 Million Essential Drug Facility

Shanghai Modern Hasen (Shangqiu) Pharmaceutical, a subsidiary of Shanghai Modern Pharmaceutical , announced plans to invest 277 million RMB ($43.6 million) to build a production facility in Shangqiu, Henan province. The new plant will produce drugs that are listed on the essential drug list. More details.... Stock Symbol: (SHA: 600420)     Share this with colleagues: